Markets.com Logo
markets.com

RNAZ

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

RNAZ.US refers to the common stock of TransCode Therapeutics, Inc., a biopharmaceutical company focused on developing RNA therapies for cancer treatment. This symbol is used to identify and trade the company's shares on the Nasdaq stock exchange.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

iShares RNA ETF Price Determinants: Issuer's Reputation: BlackRock's credibility significantly influences investor confidence and demand for RNAZ shares. Expense Ratio: A lower expense ratio compared to similar ETFs attracts investors, potentially driving up demand and the price. Underlying Index Performance: RNAZ's price closely tracks the performance of its underlying index of mRNA technology and research companies. Company-Specific News: Developments regarding companies held in the RNAZ ETF (e.g., clinical trial results, regulatory approvals, partnerships) can impact its price. Industry Trends: Overall growth and innovation within the mRNA technology sector influence investor sentiment and the ETF's valuation. Market Sentiment: General market optimism or pessimism, especially towards growth stocks and biotechnology, impacts RNAZ's price. Interest Rate Changes: Rising interest rates can make growth stocks less attractive, potentially decreasing RNAZ's price. Inflation Rates: High inflation can erode the value of future earnings, affecting the valuation of RNAZ's underlying holdings. Economic Growth: A strong economy can fuel investment in innovative technologies, positively influencing RNAZ's price. Regulatory Environment: Changes in regulations related to biotechnology and pharmaceuticals can significantly impact the prospects of RNAZ's holdings. Technological Advancements: Breakthroughs in mRNA technology can increase investor enthusiasm and drive up the price of the ETF. Competition: The emergence of competing mRNA technologies or ETFs can dilute investor interest in RNAZ. Supply and Demand: Basic economics dictate that increased demand for RNAZ shares will raise its price, while increased supply can lower it. Geopolitical Factors: Global events and political instability can affect investor confidence and market volatility, impacting RNAZ's price. Fund Flows: Large inflows into RNAZ can drive up its price, while significant outflows can put downward pressure on it. Liquidity: The ease with which RNAZ shares can be bought and sold influences its price stability. Currency Fluctuations: For international investors, currency exchange rates can impact the real return on their RNAZ investment. Management Strategy: The ETF manager's active decisions about rebalancing and stock selection influence the ETF's performance.

People Also Watch

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Julian Parker|--
McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Julian Parker|--
Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Julian Parker|--

Latest Education Articles

Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Gold Scalping Strategy: How Scalping XAU/USD Works

Gold Scalping Strategy: How Scalping XAU/USD Works

Julian Parker|--
Recommended Topics
markets.com